mCSPC

Is Apalutamide Safe, Effective in Older Patients? Examining TITAN, SPARTAN
The randomized TITAN and SPARTAN studies investigated the use of apalutamide in combination with androgen-deprivation therapy (ADT) for the treatment of metastatic castration-sensitive prostate cancer (mCSPC) and non-metastatic castration-resistant prostate cancer (nmCRPC), respectively. The combination was found to maintain health-related quality of life (HRQOL) and improve outcomes. ...
Advertisement
Advertisement

Prostate Cancer Knowledge Hubs

Prostate Cancer
Prostate Cancer

Conference Coverage

Advertisement
Advertisement